Delivery Order SPE2DB22D1106-SPE2DB25FEZW9
- Not listed
- The Defense Logistics Agency awarded a $24,347.36 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, issued competitively under open procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. DESCOVY is an antiretroviral medication...
- The Defense Logistics Agency awarded a $33,272.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-unit packaging) with a completion date of July 22, 2025. This non-set-aside competitive award was issued on July 21, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's ongoing pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,795.72 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV treatment medication combining emtricitabine and tenofovir alafenamide,...
- The Defense Logistics Agency awarded a delivery order valued at $5,842.52 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units. The contract is a firm fixed price delivery order with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,208.36 to AmerisourceBergen Drug Corp for 30 tablets of DESCOVY 200-25 mg, an antiretroviral medication used in HIV treatment and prevention. The contract, executed on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, served as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of DESCOVY 200-25 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $19,179.38. This non-competitive delivery order is expected to be completed by July 23, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV prevention and treatment medication, reflecting the federal government's ongoing...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,072.97 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,898.04 for DESCOVY 200-25 mg tablets (30-count units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed price contract, executed without set-aside provisions, represents a competitively awarded procurement under the agency's pharmaceutical supply chain. The award is performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, leveraging the...
- The Defense Logistics Agency awarded a delivery order valued at $14,991.82 to AmerisourceBergen Drug Corp for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through full and open competition. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain awarded a $47,021.50 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of DESCOVY 200-25 mg tablets (30-unit packs). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task order...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZW9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the pharmaceutical supply requirements of military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent performance across federal medical procurement demonstrates its capability to meet competitive bidding requirements and fulfill critical medication needs across multiple therapeutic domains for defense and federal health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 7/25/25 |